Home » Newsletters » BioWorld Science

BioWorld Science

July 27, 2016

View Archived Issues

Apricus expands Vitaros agreement with Ferring, terminates agreement with Sandoz

Prokarium receives funding to develop three new vaccines

Cerecor announces research grant for the development of CERC-501

SRI International patents MAP4K4 inhibitors

Scripps Research Institute discloses agents to treat cancer

PTC provides E.U. and U.S. update on Translarna program

Interim data from REMARC study of Revlimid do not support regulatory filing

Parion Sciences begins phase II study of P-321

Genentech and Constellation Pharmaceuticals develop KAT2B inhibitors

Genentech and Constellation Pharmaceuticals jointly patent KDM2B inhibitors

NantHealth and University of Utah partner on Heritage 1K project

Kite Pharma licenses technology from UCLA

First-in-human data on BACE1 inhibitor LY-3202626

NY-ESO SPEAR T-cell therapy receives orphan drug designation in the E.U.

First patient dosed in phase III study of roxadustat in Japan

Tokai to discontinue ARMOR3-SV study of galeterone based on DMC recommendation

Embera Neurotherapeutics receives grant to continue development of drug for cocaine addition

Amgen and Novartis report first-in-human data on AMG-520

Preclinical and early clinical evaluation of MK-8719

Enigma Biomedical, Biogen and Merck & Co. establish research collaboration

Results from phase Ib trial evaluating second-generation NGF-ECB implants in patients with AD

Hisamitsu reports phase II results for HP-3150 analgesic transdermal patch

Trek Therapeutics gains rights to two HCV drugs from Vertex

NIAID gives grant to Forge Therapeutics to develop drugs for multidrug-resistant bacteria

Viking Therapeutics reports results of study in mice with VK-0214

Merck & Co. returns all rights to SLIT-tablets to ALK-Abello

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...